Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
TRAILR2/TNFRSF10B Antibody (HS201) - BSA Free, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP280066
Description
TRAILR2/TNFRSF10B Monoclonal specifically detects TRAILR2/TNFRSF10B in Human samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin, Block/Neutralize.Specifications
TRAILR2/TNFRSF10B | |
Monoclonal | |
1 mg/mL | |
Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Block/Neutralize | |
CD262, CD262 antigen, death domain containing receptor for TRAIL/Apo-2L, Death receptor 5, DR5TRICK2B, Fas-like protein, KILLER/DR5, KILLERapoptosis inducing protein TRICK2A/2B, TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2apoptosis inducing receptor TRAIL-R2, TRAILR2cytotoxic TRAIL receptor-2, TRICK2, TRICK2A, TRICKB, tumor necrosis factor receptor superfamily member 10B, tumor necrosis factor receptor superfamily, member 10b, tumor necrosis factor receptor-like protein ZTNFR9, ZTNFR9 | |
Mouse | |
Protein G purified | |
RUO | |
Primary | |
Recognizes human TRAILR2/TNFRSF10B. Does not cross-react with human TRAIL-R1, -R3 or -R4. | |
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. | |
IgG1 |
Flow Cytometry, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Blocking Assay | |
HS201 | |
Unconjugated | |
PBS containing 10% glycerol | |
TNFRSF10B | |
Recombinant human TRAILR2/TNFRSF10B (DR5). | |
100 μg | |
Apoptosis, Biologically Active Proteins, Cancer, Death Receptor Signaling Pathway | |
8795 | |
Human | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction